Solventum Corporation Releases Transcript of BofA 2025 Healthcare Conference Presentation
Solventum Corporation has released a transcript from its participation in the BofA Securities 2025 Healthcare Conference held on May 13, 2025. CEO Bryan Hanson and CFO Wayde McMillan discussed the company's progress since going public a year ago, highlighting a rapid market transformation and an increase in growth guidance. McMillan noted a projected growth rate of 2.5%, more than double that of 2024, while addressing challenges related to separation and ERP implementation. The full transcript is available online.
Solventum Corporation recently published a transcript from their participation in the BofA Securities 2025 Healthcare Conference, which took place on May 13, 2025, at 2:20 p.m. PDT. The event featured Bryan Hanson, Chief Executive Officer, and Wayde McMillan, Chief Financial Officer of Solventum, alongside Bank of America Analyst Travis Steed. During the conference, the Solventum executives reflected on the company's progress since becoming a public entity a year ago. Bryan Hanson noted, "It's actually hard to believe it was only a year ago that we spun, because so much has happened." He highlighted the unexpectedly rapid transformation within the market, which has allowed the company to raise its guidance for the year. Wayde McMillan discussed the company's growth, stating, "Even the 2.5%, we think is a good strong growth rate. It's more than double what we grew in all of 2024." He also elaborated on the challenges related to the separation and ERP implementation, expressing confidence in the team handling these processes. The full transcript can be accessed through the link below.
